和邦生物：2025年半年度归属于上市公司股东的净利润为51771523.37元

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [2] Financial Performance - The company achieved operating revenue of 3,921,052,446.51 yuan for the first half of 2025, representing a year-on-year decrease of 19.13% [2] - The net profit attributable to shareholders of the listed company was 51,771,523.37 yuan, reflecting a year-on-year decline of 73.07% [2]